Fidelity Investments’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-1,278,929
| Closed | -$8.02M | – | 4385 |
|
|
2018
Q3 | $8.02M | Sell |
1,278,929
-198,300
| -13% | -$1.24M | ﹤0.01% | 1996 |
|
|
2018
Q2 | $11.9M | Buy |
1,477,229
+5,000
| +0.3% | +$40.2K | ﹤0.01% | 1898 |
|
|
2018
Q1 | $11M | Sell |
1,472,229
-382,927
| -21% | -$2.86M | ﹤0.01% | 1937 |
|
|
2017
Q4 | $11M | Sell |
1,855,156
-592,000
| -24% | -$3.52M | ﹤0.01% | 1924 |
|
|
2017
Q3 | $18M | Sell |
2,447,156
-223,040
| -8% | -$1.64M | ﹤0.01% | 1730 |
|
|
2017
Q2 | $18.1M | Sell |
2,670,196
-317,930
| -11% | -$2.16M | ﹤0.01% | 1719 |
|
|
2017
Q1 | $28.2M | Sell |
2,988,126
-592,030
| -17% | -$5.59M | ﹤0.01% | 1549 |
|
|
2016
Q4 | $30.9M | Buy |
3,580,156
+119,000
| +3% | +$1.03M | ﹤0.01% | 1505 |
|
|
2016
Q3 | $21.9M | Buy |
3,461,156
+117,933
| +4% | +$747K | ﹤0.01% | 1634 |
|
|
2016
Q2 | $14.1M | Sell |
3,343,223
-933,056
| -22% | -$3.94M | ﹤0.01% | 1822 |
|
|
2016
Q1 | $18.6M | Sell |
4,276,279
-966,000
| -18% | -$4.21M | ﹤0.01% | 1690 |
|
|
2015
Q4 | $32.1M | Sell |
5,242,279
-89,872
| -2% | -$551K | ﹤0.01% | 1445 |
|
|
2015
Q3 | $30.5M | Buy |
5,332,151
+89,872
| +2% | +$514K | ﹤0.01% | 1474 |
|
|
2015
Q2 | $39.1M | Sell |
5,242,279
-212,267
| -4% | -$1.58M | 0.01% | 1446 |
|
|
2015
Q1 | $32.6M | Buy |
5,454,546
+212,267
| +4% | +$1.27M | ﹤0.01% | 1537 |
|
|
2014
Q4 | $39.6M | Buy |
5,242,279
+198,737
| +4% | +$1.5M | 0.01% | 1442 |
|
|
2014
Q3 | $26.2M | Buy |
5,043,542
+967,496
| +24% | +$5.02M | ﹤0.01% | 1627 |
|
|
2014
Q2 | $17.6M | Sell |
4,076,046
-329,900
| -7% | -$1.42M | ﹤0.01% | 1853 |
|
|
2014
Q1 | $18M | Sell |
4,405,946
-1,765,100
| -29% | -$7.22M | ﹤0.01% | 1805 |
|
|
2013
Q4 | $32.9M | Sell |
6,171,046
-2,587,300
| -30% | -$13.8M | ﹤0.01% | 1513 |
|
|
2013
Q3 | $44.1M | Buy |
8,758,346
+255,100
| +3% | +$1.28M | 0.01% | 1357 |
|
|
2013
Q2 | $37.9M | Buy |
+8,503,246
| New | +$37.9M | 0.01% | 1375 |
|